113 related articles for article (PubMed ID: 10098670)
41. Individual subunits of heterodimers comprised of retinoic acid and retinoid X receptors interact with their ligands independently.
Kersten S; Dawson MI; Lewis BA; Noy N
Biochemistry; 1996 Mar; 35(12):3816-24. PubMed ID: 8620004
[TBL] [Abstract][Full Text] [Related]
42. [Retinoid antagonists].
Umemiya H; Kagechika H; Fukasawa H; Hashimoto Y; Shudo K
Yakugaku Zasshi; 1996 Dec; 116(12):928-41. PubMed ID: 8993231
[TBL] [Abstract][Full Text] [Related]
43. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands.
Mills KJ; Vollberg TM; Nervi C; Grippo JF; Dawson MI; Jetten AM
Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863
[TBL] [Abstract][Full Text] [Related]
44. Retinoid regulation of the phosphoenolpyruvate carboxykinase gene in liver.
Shin DJ; Odom DP; Scribner KB; Ghoshal S; McGrane MM
Mol Cell Endocrinol; 2002 Sep; 195(1-2):39-54. PubMed ID: 12354671
[TBL] [Abstract][Full Text] [Related]
45. Characterization of synthetic retinoids with selectivity for retinoic acid or retinoid X nuclear receptors.
LeMotte PK; Keidel S; Apfel CM
Biochim Biophys Acta; 1996 Mar; 1289(2):298-304. PubMed ID: 8600988
[TBL] [Abstract][Full Text] [Related]
46. Activation of specific RXR heterodimers by an antagonist of RXR homodimers.
Lala DS; Mukherjee R; Schulman IG; Koch SS; Dardashti LJ; Nadzan AM; Croston GE; Evans RM; Heyman RA
Nature; 1996 Oct; 383(6599):450-3. PubMed ID: 8837780
[TBL] [Abstract][Full Text] [Related]
47. Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors.
Zacheis D; Dhar A; Lu S; Madler MM; Klucik J; Brown CW; Liu S; Clement F; Subramanian S; Weerasekare GM; Berlin KD; Gold MA; Houck JR; Fountain KR; Benbrook DM
J Med Chem; 1999 Oct; 42(21):4434-45. PubMed ID: 10543887
[TBL] [Abstract][Full Text] [Related]
48. Diminished teratogenicity of retinoid X receptor-selective synthetic retinoids.
Jiang H; Penner JD; Beard RL; Chandraratna RA; Kochhar DM
Biochem Pharmacol; 1995 Aug; 50(5):669-76. PubMed ID: 7669070
[TBL] [Abstract][Full Text] [Related]
49. RAR and RXR selective ligands cooperatively induce apoptosis and neuronal differentiation in P19 embryonal carcinoma cells.
Horn V; Minucci S; Ogryzko VV; Adamson ED; Howard BH; Levin AA; Ozato K
FASEB J; 1996 Jul; 10(9):1071-7. PubMed ID: 8801169
[TBL] [Abstract][Full Text] [Related]
50. Ligand-dependent activation of transcription in vitro by retinoic acid receptor alpha/retinoid X receptor alpha heterodimers that mimics transactivation by retinoids in vivo.
Dilworth FJ; Fromental-Ramain C; Remboutsika E; Benecke A; Chambon P
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):1995-2000. PubMed ID: 10051583
[TBL] [Abstract][Full Text] [Related]
51. Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid.
Egea PF; Mitschler A; Rochel N; Ruff M; Chambon P; Moras D
EMBO J; 2000 Jun; 19(11):2592-601. PubMed ID: 10835357
[TBL] [Abstract][Full Text] [Related]
52. Synthesis of 9E- and 9Z-locked retinoic acid analogs as ligands for RAR and RXR.
Katsuta Y; Aoyama Y; Osone H; Wada A; Uchiyama S; Kitamoto T; Masushige S; Kato S; Ito M
Chem Pharm Bull (Tokyo); 1994 Dec; 42(12):2659-61. PubMed ID: 7697779
[TBL] [Abstract][Full Text] [Related]
53. [Studies on the structure-activity relationship of retinoids--Hansch analysis and 3D-OSAR studies on specific ligands of retinoid x receptor].
Huang N; Chu F; Guo Z
Yao Xue Xue Bao; 1998 Jun; 33(6):442-8. PubMed ID: 12016914
[TBL] [Abstract][Full Text] [Related]
54. RAR-, not RXR, ligands inhibit cell activation and prevent apoptosis in B-lymphocytes.
Lømo J; Smeland EB; Ulven S; Natarajan V; Blomhoff R; Gandhi U; Dawson MI; Blomhoff HK
J Cell Physiol; 1998 Apr; 175(1):68-77. PubMed ID: 9491782
[TBL] [Abstract][Full Text] [Related]
55. Methyl-substituted conformationally constrained rexinoid agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and prevention.
Desphande A; Xia G; Boerma LJ; Vines KK; Atigadda VR; Lobo-Ruppert S; Grubbs CJ; Moeinpour FL; Smith CD; Christov K; Brouillette WJ; Muccio DD
Bioorg Med Chem; 2014 Jan; 22(1):178-85. PubMed ID: 24359708
[TBL] [Abstract][Full Text] [Related]
56. Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors.
Seol W; Choi HS; Moore DD
Mol Endocrinol; 1995 Jan; 9(1):72-85. PubMed ID: 7760852
[TBL] [Abstract][Full Text] [Related]
57. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers.
Vivat V; Zechel C; Wurtz JM; Bourguet W; Kagechika H; Umemiya H; Shudo K; Moras D; Gronemeyer H; Chambon P
EMBO J; 1997 Sep; 16(18):5697-709. PubMed ID: 9312028
[TBL] [Abstract][Full Text] [Related]
58. On the role of ligand in retinoid signaling: positive cooperativity in the interactions of 9-cis retinoic acid with tetramers of the retinoid X receptor.
Kersten S; Pan L; Noy N
Biochemistry; 1995 Oct; 34(43):14263-9. PubMed ID: 7578026
[TBL] [Abstract][Full Text] [Related]
59. LXR, a nuclear receptor that defines a distinct retinoid response pathway.
Willy PJ; Umesono K; Ong ES; Evans RM; Heyman RA; Mangelsdorf DJ
Genes Dev; 1995 May; 9(9):1033-45. PubMed ID: 7744246
[TBL] [Abstract][Full Text] [Related]
60. Design of selective nuclear receptor modulators: RAR and RXR as a case study.
de Lera AR; Bourguet W; Altucci L; Gronemeyer H
Nat Rev Drug Discov; 2007 Oct; 6(10):811-20. PubMed ID: 17906643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
